Carlos Gil Ferreira

13PUBLICATIONS
79CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 24, 2026
Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918).

|Feb 13, 2026
Modulation of Patient-Derived Tumor Organoids by SARS-CoV-2 Variants Across Cancer Types: A Study Combining Morphology, Inflammation, and Whole-Exome Profiling.

Danielle Ferreira, Tayanne Sassaro, Anael Viana Pinto Alberto

|Jan 16, 2025
Later lines of systemic therapy in patients with metastatic colorectal cancer: real-world data from a setting with barriers to access cancer therapies.

Alexandre A Jácome, Maria Cecília Mathias-Machado, Mariana Gil

|Nov 21, 2024
Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil.

Rodrigo Dienstmann, Leonard M da Silva, Fernanda Orpinelli Ramos do Rego

|Oct 19, 2023
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective.

Bruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa E Silva

|Sep 28, 2023
EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing.

Tatiane Montella, Mariano Zalis, Mauro Zukin

Pageof 3

Frequent Collaborators

4 joint publications

Rodrigo Dienstmann

4 joint publications

Clarissa Baldotto

3 joint publications

Tatiane Montella

3 joint publications

Pedro De Marchi